Pathology

(redirected from Molecular pathology)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

PATHOLOGY, med. jur. The science or doctrine of diseases. In cases of homicides, abortions, and the like, it is of great consequence to the legal practitioner to be acquainted, in some degree, with pathology. 2 Chit. Pr. 42, note.

References in periodicals archive ?
In addition to CLSI, other organizations such as the Centers for Disease Control and Prevention and the American College of Medical Genetics have published recommendations on approaches to validation for certain types of molecular pathology testing.
Fundamental understanding of key molecular pathology controls and certain basics, such as potential interference by genomic DNA in reverse transcription-PCR (RT-PCR) amplification of cDNAs, are assumed by the authors, but importantly, they are not ignored altogether.
The company's Learning Theater, located next to its main booth in the Exhibition Hall, will feature international experts speaking on companion diagnostics, molecular pathology, next-generation sequencing and immunohistochemistry.
According to the paper, the tumour marker testing is a major opportunity for DNA probes, particularly for the application of molecular pathology technologies.
Neurodegeneration; the molecular pathology of dementia and movement disorders, 2d ed.
The College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology are collaborating to provide an international guideline for biomarker testing in lung cancer.
Trained in molecular biology, Holland now works in technical marketing; Farkas runs a molecular pathology laboratory in Michigan.
DNA Technology in the Clinical Laboratory, the 8th Annual Seminar on Molecular Pathology, William Beaumont Hospital, Royal Oak, Michigan, March 25-27, 1999, cosponsored by the AACC Molecular Pathology Division.
DETROIT -- Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery, today announced that it has launched Good Laboratory Practice (GLP) compliant molecular pathology services supporting preclinical safety studies.
They address epidemiology, the histopathology of various tumors, current imaging techniques, molecular pathology, staging, preneoplastic and preinvasive lesions, pitfalls, differential diagnosis, and complications, with many images.
With the ability to offer GLP compliant studies as part of the PhaseZERO services platform, the company is now adding preclinical safety studies for regulatory submission to its existing services in the areas of molecular pathology, compound potency, efficacy, disposition and safety.

Full browser ?